progressive familial intrahepatic cholestasis
Hepatology · 2024–2025
2decisions
1medicine
2carried consumer input
71individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| odevixibat Treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older with elevated serum bile acids and pruritus. | Mar 2025 | Recommended with restriction | 36 individuals |
| odevixibat Treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older with elevated serum bile acids and/or symptomatic pruritus. | Jul 2024 | Not recommended | 35 individuals PFIC Network · Related Disorders Australia · Liver Foundation |
Who spoke
PFIC Network · Related Disorders Australia · Liver Foundation
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.